In the univariate analysis, NAFLD development, smaller tumor size, less lymph node metastasis, earlier TNM stage, lower histologic grade, high ER expression, HER2-negative status, no chemotherapy, and no radiotherapy were associated with improved DFS (Table 3). This evidence concerns the gene ESR1 and metabolic dysfunction-associated steatotic liver disease.